Dermira, Inc.
DERM
DERM was delisted on the 19th of February, 2020.
135 hedge funds and large institutions have $491M invested in Dermira, Inc. in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 67 increasing their positions, 28 reducing their positions, and 28 closing their positions.
139% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 28
0.86% less ownership
Funds ownership: 96.68% → 95.82% (-0.86%)
7% less funds holding
Funds holding: 145 → 135 (-10)
28% less capital invested
Capital invested by funds: $683M → $491M (-$192M)
29% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 28
30% less call options, than puts
Call options by funds: $1.01M | Put options by funds: $1.44M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$15.8M |
| 2 |
BlackRock
New York
|
+$8.18M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
+$7.86M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.59M |
| 5 |
FAM
Fred Alger Management
New York
|
+$5.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$17.3M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$8.63M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$7.6M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$5.42M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$5.29M |
DERM Hedge Fund Activity: Q2 2019 in Review
135 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Dermira, Inc. (DERM) for Q2 2019, worth a combined $491M — down 28% from $683M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of DERM and 20 opened new positions — a net loss of 8 holders — while 28 trimmed existing stakes and 67 added.
The largest buyer was PFM Health Sciences, adding an estimated $15.8M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $17.3M sold.
- 135 institutional investors held Dermira, Inc. (DERM) as of Q2 2019, down from 145 in Q1 2019.
- Funds reported $491M of Dermira, Inc. stock for Q2 2019, down 28% quarter-over-quarter.
- 20 funds opened new Dermira, Inc. positions in Q2 2019 and 28 closed out, a net change of -8 holders.
- The largest Dermira, Inc. buyer in Q2 2019 was PFM Health Sciences, an estimated $15.8M added.
- The largest Dermira, Inc. seller in Q2 2019 was Adage Capital Partners, an estimated $17.3M sold.
Based on aggregated 13F filings for Q2 2019.